Of course, some serious complications can be the result of an injury, so the problem does not necessarily arise in the cases where the complaint is from a disease or other medical problem. The problem is that our current system of insurance has created a system that is incapable of handling the problem at hand. The problem is this: the system is built on a fundamental misconception: the idea that we are human.

For this reason, we are in a situation where many physicians will soon leave the field of medicine. The German system is a huge, complicated experiment. It is not at all clear whether it will succeed or fail. I can tell you that we are not going to be managing our patients any more, not even through a contract for a few years. The German health care system has been designed to allow the government to set spending limits to protect the country's budget. In Germany, government policy has already taken the form of allowing doctors to choose what treatments they will see and to choose from a limited number of doctors who can prescribe and provide treatment. The levosalbutamol is not the only player in health care. The country also has a national health insurance system, which also sets limits on spending and sets up a system of health care committees that oversee the work of each hospital to make sure there is no waste.

We have to be cautious about the number of patients we manage to treat, because we must not leave out the elderly, the sick and the people whose conditions prevent them from working. There is a limit in our medical care and our spending, but we cannot make up for it by reducing the number of patients we treat. In the United States, where the government has provided free health care through the Social Security system, Americans are often told that if they go to the doctor, their health insurance will pay for everything. There may still be some in the system, but these doctors will be very busy trying new treatments to see if they work. The card is the key to access to care; the government is now spending millions of dollars to create a new health care system in the French countryside where doctors can treat a wide variety of conditions.

The card is not a payment but rather a form of care management and is designed to make access to care as cheap as possible. In this system, it is not the doctors that charge, but the government. Germany, for years the model for other countries in the EU, is now attempting to change course. Germans will be able to afford their own treatment and the rest will pay a monthly insurance fee.


Combivent is prescribed to treat chronic obstructive pulmonary disease. The medication works by dilating and enlarging the airways via relaxation of the muscles of respiratory tract.